Litcius/Paper detail

Non-Coding RNA m6A Modification in Cancer: Mechanisms and Therapeutic Targets

Chen Da-hong, Jigang Zhang, Chuan-Xing Wu, Li Qin

2021Frontiers in Cell and Developmental Biology63 citationsDOIOpen Access PDF

Abstract

Recently, N6-methyl-adenosine (m6A) ribonucleic acid (RNA) modification, a critical and common internal RNA modification in higher eukaryotes, has generated considerable research interests. Extensive studies have revealed that non-coding RNA m6A modifications (e.g. microRNAs, long non-coding RNAs, and circular RNAs) are associated with tumorigenesis, metastasis, and other tumour characteristics; in addition, they are crucial molecular regulators of cancer progression. In this review, we discuss the relationship between non-coding RNA m6A modification and cancer progression from the perspective of various cancers. In particular, we focus on important mechanisms in tumour progression such as proliferation, apoptosis, invasion and metastasis, tumour angiogenesis. In addition, we introduce clinical applications to illustrate more vividly that non-coding RNA m6A modification has broad research prospects. With this review, we aim to summarize the latest insights and ideas into non-coding RNA m6A modification in cancer progression and targeted therapy, facilitating further research.

Topics & Concepts

RNAmicroRNACarcinogenesisLong non-coding RNANon-coding RNABiologyMetastasisCancer researchCircular RNAAngiogenesisComputational biologyCancerGeneGeneticsRNA modifications and cancerCancer-related molecular mechanisms researchRNA Research and Splicing
Non-Coding RNA m6A Modification in Cancer: Mechanisms and Therapeutic Targets | Litcius